Searchable abstracts of presentations at key conferences in endocrinology

ea0008p36 | Diabetes, metabolism and cardiovascular | SFE2004

Vasculopathy in Turner Syndrome: Arterial Dilatation and Intimal Thickening without Endothelial Dysfunction

Ostberg JE , Donald AE , Storry C , McCarthy C , Halcox JP , Conway GS

Dissection or rupture of the aorta accounts for death in 2-8% of women with Turner Syndrome (TS), and dilatation of the aortic root, has been reported as a predisposing factor. We compared measures of arterial structure, stiffness and endothelial function to investigate whether women with TS have a fundamental arterial wall defect which extends beyond the arch of the aorta. Local Ethics Committee approval was obtained.Age-matched women with TS (n=93), 46...

ea0008dp16 | Diabetes, metabolism and cardiovascular | SFE2004

Vasculopathy in Turner Syndrome: Arterial Dilatation and Intimal Thickening without Endothelial Dysfunction

Ostberg JE , Donald AE , Storry C , McCarthy C , Halcox JP , Conway GS

Dissection or rupture of the aorta accounts for death in 2-8% of women with Turner Syndrome (TS), and dilatation of the aortic root, has been reported as a predisposing factor. We compared measures of arterial structure, stiffness and endothelial function to investigate whether women with TS have a fundamental arterial wall defect which extends beyond the arch of the aorta. Local Ethics Committee approval was obtained.Age-matched women with TS (n=93), 46...

ea0005oc8 | Reproduction and Development | BES2003

Classification of the spectrum of aortic dysmorphology by magnetic resonance imaging in adults with Turner syndrome

Ostberg J , Brookes J , McCarthy C , Conway G

IntroductionCardiovascular complications are the main cause of increased mortality in Turner Syndrome (TS). We have previously described a high prevalence of occult aortic dysmorphology in women with TS. The aim of this study was to introduce a classification system for the variety of appearances seen by magnetic resonance imaging (MRI).Method98 women (median age 29.0, range 18.1-64.2 years) underwent MRI scanning of the aorta. MRI appearances were correlated with ...

ea0083domno2 | Diabetes, Obesity, Metabolism and Nutrition | EYES2022

Placental signalling contributes to adipokine dysregulation and systemic insulin resistance in gestational diabetes mellitus

C. J. McElwain , A Musumeci , S. Manna , I Sylvester , F. P. McCarthy , C. M. McCarthy

Background: Placental signalling has been postulated to drive inflammation, endothelial dysfunction and insulin resistance in gestational diabetes mellitus (GDM).Objectives: To determine if placental signalling contributes to systemic insulin resistance in GDM.Methods: Adiponectin, leptin, adipsin and resistin in placental and omental explant culture supernatants (n=10 GDM and n=10 control) and maternal plasma (n=20 GDM and n=20 co...

ea0009p89 | Endocrine tumours and neoplasia | BES2005

Cell cycle dysregulation in breast cancer - the roles of Jab1 and Archipelago

Bonner S , Morris D , Korbonits M , Laban C , McCarthy K , Al-Mufti R , Carpenter R , Grossman A

The cell cycle occupies a pivotal role in the control of cellular proliferation, a critical point being activation of CyclinE which is held in check by the inhibitor p27. CyclinE is targeted for degradation by the F-box protein Archipelago (Ago/Fbw7/cdc4), while p27 is exported out of the nucleus by Jun activation domain-binding protein 1 (Jab1). Over-expression of CyclinE has been reported in breast cancer. We have now explored the role of Jab1 and Ago in mediating changes in...

ea0007oc24 | Endocrine tumours | BES2004

Microarray analysis of IGF-I mRNA positive and negative breast tumours

Laban C , McCarthy K , Ogunkolade B , Bustin S , Ahmed S , Carpenter R , Jenkins P

Background: There is considerable evidence to support a role for the GH/IGF-I axis in the development of breast cancer. We have previously demonstrated that IGF-I is expressed in both normal and malignant breast tissue, but that approximately 10% of primary breast cancers reveal no IGF-I mRNA expression. However the molecular differences between IGF-I positive and IGF-I negative tumours is unknown.Aims: To investigate the molecular differences between IG...

ea0006oc1 | Young Endocrinologist Session | SFE2003

Bicuspid Aortic Valve is associated with increased arterial stiffness in adult women with Turner Syndrome

Ostberg J , Donald A , Storry C , Lloyd N , McCarthy C , Halcox J , Conway G

IntroductionCardiovascular disease, which may be structural or ischaemic, is the major cause of morbidity and mortality for women with Turner Syndrome (TS). This study investigated arterial augmentation index (AI%) and pulse wave velocity (PWV) as measures of arterial stiffness in adults with TS. A more positive AI% and greater PWV indicate increased arterial stiffness.Method66 women with TS and 8 normal wome...

ea0006dp31 | Diabetes, metabolism and cardiovascular | SFE2003

Bicuspid Aortic Valve is associated with increased arterial stiffness in adult women with Turner Syndrome

Ostberg J , Donald A , Storry C , Lloyd N , McCarthy C , Halcox J , Conway G

IntroductionCardiovascular disease, which may be structural or ischaemic, is the major cause of morbidity and mortality for women with Turner Syndrome (TS). This study investigated arterial augmentation index (AI%) and pulse wave velocity (PWV) as measures of arterial stiffness in adults with TS. A more positive AI% and greater PWV indicate increased arterial stiffness.Method66 women with TS and 8 normal wome...

ea0005p134 | Endocrine Tumours and Neoplasia | BES2003

Expression of IGF-I in normal and malignant breast tissue and its association with tumour size

Laban C , McCarthy K , Ogunkolade W , Bustin S , Carpenter R , Jenkins P

Background:The growth hormone/insulin-like growth factor-I (GH/IGF-I) axis has been increasingly implicated in the development of breast cancer. Previously we have demonstrated the local expression of IGF-I in normal and malignant breast tissue. However the correlation of this local expression with clinical factors has not fully been investigated.Aims: (i) To quantify the mRNA levels of IGF-I in normal and malignant breast tissue and (ii) to identify any correlation betwee...

ea0007p95 | Endocrine tumours and neoplasia | BES2004

The effects of surgery and tamoxifen on serum IGF-I and IGFBP3 levels in breast cancer

McVittie C , McCarthy K , Laban C , Miraki-Moud F , Camacho-Hubner C , Bustin S , Carpenter R , Jenkins P

Background: Serum IGF-I and IGFBP-3 levels respectively have a positive and negative association with subsequent risk of breast cancer. The anti-oestrogen tamoxifen is widely used as adjunctive therapy after resection of primary breast tumours. Tamoxifen has been reported to influence serum IGF-I, although its effects on BP-3 are unknown. The effects of tumour resection itself on IGF-I and BP-3 levels are unclear.Aims: To determine the effects of surgery...